ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 62 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,075 | +17.9% | 13,582 | +35.6% | 0.00% | – |
| Q2 2023 | $3,455 | +8.5% | 10,015 | +147.0% | 0.00% | – |
| Q1 2023 | $3,183 | -33.1% | 4,055 | -14.8% | 0.00% | – |
| Q4 2022 | $4,760 | -68.3% | 4,760 | -71.4% | 0.00% | – |
| Q3 2022 | $15,000 | -91.8% | 16,635 | -90.0% | 0.00% | – |
| Q2 2022 | $184,000 | +1050.0% | 166,298 | +1373.8% | 0.00% | – |
| Q1 2022 | $16,000 | -71.4% | 11,284 | -54.5% | 0.00% | – |
| Q4 2021 | $56,000 | -91.9% | 24,787 | -85.1% | 0.00% | – |
| Q3 2021 | $692,000 | +2.2% | 166,095 | +16.6% | 0.00% | – |
| Q2 2021 | $677,000 | +2407.4% | 142,446 | +4233.6% | 0.00% | – |
| Q1 2021 | $27,000 | +285.7% | 3,287 | -14.9% | 0.00% | – |
| Q3 2020 | $7,000 | – | 3,862 | +3762.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 100 | -75.7% | 0.00% | – |
| Q4 2019 | $1,000 | -87.5% | 412 | -74.6% | 0.00% | – |
| Q3 2019 | $8,000 | -38.5% | 1,625 | -11.4% | 0.00% | – |
| Q2 2019 | $13,000 | – | 1,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,710,000 | 0.88% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $570,000 | 0.49% |
| Parkman Healthcare Partners LLC | 415,384 | $1,973,000 | 0.43% |
| Altium Capital Management LP | 172,218 | $818,000 | 0.19% |
| Vigilare Wealth Management | 52,535 | $250,000 | 0.15% |
| BRIGHTON JONES LLC | 332,875 | $1,581,000 | 0.08% |
| Ikarian Capital, LLC | 200,204 | $950,000 | 0.08% |
| IPG Investment Advisors LLC | 31,106 | $147,754,000 | 0.04% |
| DOWLING & YAHNKE LLC | 150,464 | $715,000 | 0.04% |
| Jump Financial, LLC | 58,225 | $276,000 | 0.03% |